Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net loss $ (14,743) $ (53,364)
Less: income (loss) from discontinued operations, net of tax 8,644 (3,839)
Net loss from continuing operations (23,387) (49,525)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Realized loss on marketable debt securities 0 18
Depreciation and amortization 4,832 6,187
Amortization of debt discount 5,236 1,485
Impairment loss 1,263 0
Amortization on right-of-use assets 227 457
Loss from investment in unconsolidated affiliates 166 0
Loss on issuance of debt 480 0
Loss from lease termination 1,357 0
Loss (gain) from disposal of fixed assets 955 (91)
Employee retention tax credit income (1,929) 0
Stock-based compensation expense 1,893 3,638
Accounts receivable allowances 1,005 11,018
Inventory valuation reserve 0 (212)
Inventory write-offs 196 0
Change in fair value of warrant liability 225 0
Change in fair value of derivative liability (437) 0
Debt extinguishment (gain) loss (838) 333
Changes in operating assets and liabilities:    
Accounts receivable 736 4,738
Inventory 313 1,360
Prepaid expenses and other current assets 1,147 (45)
Deferred tax asset 0 7,150
Other assets 0 853
Accounts payable and accrued expenses (722) 5,066
Accrued diagnostic services (5) (283)
Accrued advertising and other allowances (101) 127
Deferred revenue (338) (1,000)
Deferred tax liability 0 0
Lease liabilities (233) (1,408)
Income taxes payable (1,706) (1,292)
Other liabilities 724 (377)
Net cash used in operating activities - continuing operations (8,941) (11,803)
Net cash provided by (used in) operating activities - discontinued operations 597 (5,735)
Net cash used in operating activities (8,344) (17,538)
Cash flows from investing activities    
Proceeds from maturities of marketable securities 0 3,374
Proceeds from dispositions of property and other assets, net 120 229
Capital expenditures 0 (906)
Net cash provided by investing activities - continuing operations 120 2,697
Net cash provided by (used in) investing activities - discontinued operations 800 (275)
Net cash provided by investing activities 920 2,422
Cash flows from financing activities    
Proceeds from issuance of common stock from public offering, net 0 7,594
Proceeds from issuance of note payable 4,074 9,862
Proceeds from issuance of note payable to related party 500 0
Proceeds from issuance of convertible notes payable 3,000 0
Proceeds from issuance of common shares, net 3,558 0
Repayment of note payable (4,234) (4,249)
Repayment of convertible notes payable (27) 0
Net cash provided by financing activities - continuing operations 6,871 13,207
Net cash (used in) provided by financing activities - discontinued operations (35) 978
Net cash provided by financing activities 6,836 14,185
Decrease in cash, cash equivalents and restricted cash (588) (931)
Cash and cash equivalents at the beginning of the year 678 1,609
Cash and cash equivalents at the end of the year 90 678
Supplemental disclosures:    
Cash paid for income taxes 1,645 1,126
Interest payment on the promissory notes 1,161 3,105
Supplemental disclosure of non-cash investing and financing activities:    
Assets obtained in exchange for new finance lease obligations 0 3,783
Issuance of treasury shares as collateral for a loan 0 3
Issuance of common shares as collateral for a loan 1 0
Issuance of common stock as commitment fee for future financing 158 0
Issuance of common stock to convert outstanding convertible notes and interest 3,612 0
Issuance of liability classified warrants associated with notes payable 230 0
Net unrealized loss, investments in marketable securities 0 265
Deconsolidation of subsidiaries assets and liabilities (16,003) 0
Recognition investment in nonconsolidated subsidiaries $ 43,657 $ 0